Heat shock protein-mediated cell penetration and cytosolic delivery of macromolecules by a telomerase-derived peptide vaccine

Biomaterials

Volumn 34, Issue 30, 2013, Pages

  Lee, Seoung Ae ^a   Kim, Bo Ram ^a   Kim, Bu Kyung ^a   Kim, Dong Won ^a   Shon, Won Jun ^a   Lee, Na Rae ^b   Inn, Kyung Soo ^b   Kim, Bum Joon ^a  

^a Seoul National University   (South Korea)

^b Kyung Hee University   (South Korea)

Author keywords

Cell penetrating peptide; Heat shock protein 70; Heat shock protein 90; Telomerase

Indexed keywords

AMINO ACIDS; CELL CULTURE; DISEASES; GENE EXPRESSION; GENE THERAPY; MACROMOLECULES; VACCINES;

ANTICANCER ACTIVITIES; CELL-PENETRATING PEPTIDE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; HEAT-SHOCK PROTEIN 90; MACROMOLECULAR THERAPEUTICS; REVERSE TRANSCRIPTASES; TELOMERASE;

PEPTIDES;

CELL PENETRATING PEPTIDE; DRUG CARRIER; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; PEPTIDE VACCINE; POLYLYSINE; TELOMERASE; TERTOMOTIDE;

ANTIGEN PRESENTATION; ARTICLE; BLOOD CELL; CANCER CELL; CELLULAR DISTRIBUTION; COMPARATIVE STUDY; COMPLEX FORMATION; CONFOCAL MICROSCOPY; CONJUGATION; CONTROLLED STUDY; CYTOPLASM; DENDRITIC CELL; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG UPTAKE; ENDOCYTOSIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INTERNALIZATION; ION CONDUCTANCE; MACROMOLECULE; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN INTERACTION; WESTERN BLOTTING;

EID: 84880507288     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.06.015     Document Type: Article

References (41)

1. Vasef M.A., Ross J.S., Cohen M.B. Telomerase activity in human solid tumors. Diagnostic utility and clinical applications. Am J Clin Pathol 1999, 112:S68-S75.
2. Uchida N., Otsuka T., Shigematsu H., Maeda M., Sugio Y., Itoh Y., et al. Differential gene expression of human telomerase-associated protein hTERT and TEP1 in human hematopoietic cells. Leuk Res 1999, 23:1127-1132.
3. Kyte J.A. Cancer vaccination with telomerase peptide GV1001. Expert Opin Investig Drugs 2009, 18:687-694.
4. Bernhardt S.L., Gjertsen M.K., Trachsel S., Moller M., Eriksen J.A., Meo M., et al. Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: a dose escalating phase I/II study. Br J Cancer 2006, 95:1474-1482.
5. Brunsvig P.F., Aamdal S., Gjertsen M.K., Kvalheim G., Markowski-Grimsrud C.J., Sve I., et al. Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer. Cancer Immunol Immunother 2006, 55:1553-1564.
6. Kyte J.A., Gaudernack G., Dueland S., Trachsel S., Julsrud L., Aamdal S. Telomerase peptide vaccination combined with temozolomide: a clinical trial in stage IV melanoma patients. Clin Cancer Res 2011, 17:4568-4580.
7. Brunsvig P.F., Kyte J.A., Kersten C., Sundstrom S., Moller M., Nyakas M., et al. Telomerase peptide vaccination in NSCLC: a phase II trial in stage III patients vaccinated after chemoradiotherapy and an 8-year update on a phase I/II trial. Clin Cancer Res 2011, 17:6847-6857.
8. Greten T.F., Forner A., Korangy F., N'Kontchou G., Barget N., Ayuso C., et al. Aphase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma. BMC Cancer 2010, 10:209.
9. Kyte J.A., Trachsel S., Risberg B., Thor Straten P., Lislerud K., Gaudernack G. Unconventional cytokine profiles and development of T cell memory in long-term survivors after cancer vaccination. Cancer Immunol Immunother 2009, 58:1609-1626.
10. Frankel A.D., Pabo C.O. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 1988, 55:1189-1193.
11. Green M., Loewenstein P.M. Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 1988, 55:1179-1188.
12. Koren E., Torchilin V.P. Cell-penetrating peptides: breaking through to the other side. Trends Mol Med 2012, 18:385-393.
13. Kaplan I.M., Wadia J.S., Dowdy S.F. Cationic TAT peptide transduction domain enters cells by macropinocytosis. JControl Release 2005, 102:247-253.
14. Duchardt F., Fotin-Mleczek M., Schwarz H., Fischer R., Brock R. Acomprehensive model for the cellular uptake of cationic cell-penetrating peptides. Traffic 2007, 8:848-866.
15. Ellis R.J. Protein misassembly: macromolecular crowding and molecular chaperones. Adv Exp Med Biol 2007, 594:1-13.
16. Robert J., Menoret A., Cohen N. Cell surface expression of the endoplasmic reticular heat shock protein gp96 is phylogenetically conserved. JImmunol 1999, 163:4133-4139.
17. Eustace B.K., Jay D.G. Extracellular roles for the molecular chaperone, hsp90. Cell Cycle 2004, 3:1098-1100.
18. Tsutsumi S., Neckers L. Extracellular heat shock protein 90: a role for a molecular chaperone in cell motility and cancer metastasis. Cancer Sci 2007, 98:1536-1539.
19. Lindquist S., Craig E.A. The heat-shock proteins. Annu Rev Genet 1988, 22:631-677.
20. Morano K.A. New tricks for an old dog: the evolving world of Hsp70. Ann N Y Acad Sci 2007, 1113:1-14.
21. Calderwood S.K., Khaleque M.A., Sawyer D.B., Ciocca D.R. Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem Sci 2006, 31:164-172.
22. Ferrarini M., Heltai S., Zocchi M.R., Rugarli C. Unusual expression and localization of heat-shock proteins in human tumor cells. Int J Cancer 1992, 51:613-619.
23. Vanbuskirk A., Crump B.L., Margoliash E., Pierce S.K. Apeptide binding protein having a role in antigen presentation is a member of the HSP70 heat shock family. JExp Med 1989, 170:1799-1809.
24. Suto R., Srivastava P.K. Amechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science 1995, 269:1585-1588.
25. Eustace B.K., Sakurai T., Stewart J.K., Yimlamai D., Unger C., Zehetmeier C., et al. Functional proteomic screens reveal an essential extracellular role for hsp90 alpha in cancer cell invasiveness. Nat Cell Biol 2004, 6:507-514.
26. Sidera K., Gaitanou M., Stellas D., Matsas R., Patsavoudi E. Acritical role for HSP90 in cancer cell invasion involves interaction with the extracellular domain of HER-2. JBiol Chem 2008, 283:2031-2041.
27. Asea A., Rehli M., Kabingu E., Boch J.A., Bare O., Auron P.E., et al. Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. JBiol Chem 2002, 277:15028-15034.
28. Becker T., Hartl F.U., Wieland F. CD40, an extracellular receptor for binding and uptake of Hsp70-peptide complexes. JCell Biol 2002, 158:1277-1285.
29. Delneste Y., Magistrelli G., Gauchat J., Haeuw J., Aubry J., Nakamura K., et al. Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation. Immunity 2002, 17:353-362.
30. Berwin B., Hart J.P., Rice S., Gass C., Pizzo S.V., Post S.R., et al. Scavenger receptor-A mediates gp96/GRP94 and calreticulin internalization by antigen-presenting cells. EMBO J 2003, 22:6127-6136.
31. Zhu Y.Z., Cao M.M., Wang W.B., Wang W., Ren H., Zhao P., et al. Association of heat-shock protein 70 with lipid rafts is required for Japanese encephalitis virus infection in Huh7 cells. JGen Virol 2012, 93:61-71.
32. Das S., Laxminarayana S.V., Chandra N., Ravi V., Desai A. Heat shock protein 70 on Neuro2a cells is a putative receptor for Japanese encephalitis virus. Virology 2009, 385:47-57.
33. Reyes-Del Valle J., Chavez-Salinas S., Medina F., Del Angel R.M. Heat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cells. JVirol 2005, 79:4557-4567.
34. Wang X.J. Heat-shock protein 70 is associated with the entry of Marek's disease virus into fibroblast. Acta Virol 2011, 55:189-194.
35. Jin S., Song Y.C., Emili A., Sherman P.M., Chan V.L. JlpA of Campylobacter jejuni interacts with surface-exposed heat shock protein 90alpha and triggers signalling pathways leading to the activation of NF-kappaB and p38 MAP kinase in epithelial cells. Cell Microbiol 2003, 5:165-174.
36. Calderwood S.K., Murshid A., Gong J. Heat shock proteins: conditional mediators of inflammation in tumor immunity. Front Immunol 2012, 3:75.
37. Fittipaldi A., Ferrari A., Zoppe M., Arcangeli C., Pellegrini V., Beltram F., et al. Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins. JBiol Chem 2003, 278:34141-34149.
38. Vives E., Brodin P., Lebleu B. Atruncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. JBiol Chem 1997, 272:16010-16017.
39. Foster L.J., De Hoog C.L., Mann M. Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors. Proc Natl Acad Sci U S A 2003, 100:5813-5818.
40. Li N., Shaw A.R., Zhang N., Mak A., Li L. Lipid raft proteomics: analysis of in-solution digest of sodium dodecyl sulfate-solubilized lipid raft proteins by liquid chromatography-matrix-assisted laser desorption/ionization tandem mass spectrometry. Proteomics 2004, 4:3156-3166.
41. Arispe N., Doh M., De Maio A. Lipid interaction differentiates the constitutive and stress-induced heat shock proteins Hsc70 and Hsp70. Cell Stress Chaperones 2002, 7:330-338.